Global COVID-19 therapeutics Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 202 to 2030 based on Drug Class
Global COVID-19 therapeutics Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2022 to 2030 based on Region
North America COVID-19 therapeutics market revenue (US$ Million) by Country, 2020 to 2030
Europe COVID-19 therapeutics market revenue (US$ Million) by Country, 2020 to 2030
Asia Pacific COVID-19 therapeutics market revenue (US$ Million) by Country, 2020 to 2030
Latin America COVID-19 therapeutics market revenue (US$ Million) by Country, 2020 to 2030
The Middle East & Africa COVID-19 therapeutics market revenue (US$ Million) by Country, 2020 to 2030
Competitive Landscape
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global COVID-19 Therapeutics Market Snapshot
Chapter 4. Global COVID-19 Therapeutics Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter’s Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
4.9. Clinical Trial Analysis/Pipeline Analysis 2021
Chapter 5. Market Segmentation 1: By Drug Class Estimates & Trend Analysis
5.1. By Drug Class & Market Share, 2024 & 2034
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Drug Class:
5.2.1. Corticosteroids
5.2.1.1. Dexamethasone
5.2.1.2. Hydrocortisone
5.2.1.3. Methylprednisolone
5.2.1.4. Others (Prednisone, Others)
5.2.2. Anti-viral
5.2.2.1. Remdesivir
5.2.2.2. Nirmatrelvir
5.2.2.3. Others (Ivermectin, Others)
5.2.3. Monoclonal Antibodies
5.2.3.1. Sotrovimab
5.2.3.2. Casirivimab plus imdevimab
5.2.3.3. Others (Bamlanivimab plus etesevimab, Tixagevimab plus, cilgavimab, others)
5.2.4. Kinase Inhibitors
5.2.4.1. Baricitinib
5.2.4.2. Others (Tofacitinib, Others)
5.2.5. Others (anti-inflammatory drugs, convalescent plasma, others)
Chapter 6. COVID-19 Therapeutics Market Segmentation 2: Regional Estimates & Trend Analysis
6.1. North America
6.1.1. North America COVID-19 Therapeutics Market revenue (US$ Million) estimates and forecasts By Drug Class, 2021-2034
6.1.2. North America COVID-19 Therapeutics Market revenue (US$ Million) estimates and forecasts by country, 2021-2034
6.2. Europe
6.2.1. Europe COVID-19 Therapeutics Market revenue (US$ Million) By Drug Class, 2021-2034
6.2.2. Europe COVID-19 Therapeutics Market revenue (US$ Million) by country, 2021-2034
6.3. Asia Pacific
6.3.1. Asia Pacific COVID-19 Therapeutics Market revenue (US$ Million) By Drug Class, 2021-2034
6.3.2. Asia Pacific COVID-19 Therapeutics Market revenue (US$ Million) by country, 2021-2034
6.4. Latin America
6.4.1. Latin America COVID-19 Therapeutics Market revenue (US$ Million) By Drug Class, 2021-2034
6.4.2. Latin America COVID-19 Therapeutics Market revenue (US$ Million) by country, 2021-2034
6.5. Middle East & Africa
6.5.1. Middle East & Africa COVID-19 Therapeutics Market revenue (US$ Million) By Drug Class, 2021-2034
6.5.2. Middle East & Africa COVID-19 Therapeutics Market revenue (US$ Million) by country, 2021-2034
Chapter 7. Competitive Landscape
7.1. Major Mergers and Acquisitions/Strategic Alliances
7.2. Company Profiles
7.2.1. AstraZeneca plc
7.2.2. Celltrion Healthcare Co.,Ltd
7.2.3. Pfizer Inc.
7.2.4. Ridgeback Biotherapeutics
7.2.5. Merck & Co.
7.2.6. Veru Inc.
7.2.7. Gilead Sciences, Inc.
7.2.8. GSK plc
7.2.9. Shionogi & Company, Limited
7.2.10. NRx Pharmaceuticals, Inc.
7.2.11. Kintor Pharma-B
7.2.12. Regeneron Pharmaceuticals
7.2.13. CytoDyn
7.2.14. Atea Pharmaceuticals, Inc.
7.2.15. Amarin Corporation
7.2.16. APEIRON Biologics AG
7.2.17. Abivax SA
7.2.18. Alexion Pharmaceuticals
7.2.19. Bellerophon Therapeutics
7.2.20. Blade Therapeutics, Inc
7.2.21. Roivant Sciences
7.2.22. Synairgen
7.2.23. Sorrento Therapeutics
7.2.24. Fulcrum Therapeutics
7.2.25. Ono Pharmaceutical Co., Ltd.
7.2.26. Revive Therapeutics Ltd.
7.2.27. Eli Lilly and Company
7.2.28. Other Prominent Players
This study employed a multi-step, mixed-method research approach that integrates:
This approach ensures a balanced and validated understanding of both macro- and micro-level market factors influencing the market.
Secondary research for this study involved the collection, review, and analysis of publicly available and paid data sources to build the initial fact base, understand historical market behaviour, identify data gaps, and refine the hypotheses for primary research.
Secondary data for the market study was gathered from multiple credible sources, including:
These sources were used to compile historical data, market volumes/prices, industry trends, technological developments, and competitive insights.
Primary research was conducted to validate secondary data, understand real-time market dynamics, capture price points and adoption trends, and verify the assumptions used in the market modelling.
Primary interviews for this study involved:
Interviews were conducted via:
Primary insights were incorporated into demand modelling, pricing analysis, technology evaluation, and market share estimation.
All collected data were processed and normalized to ensure consistency and comparability across regions and time frames.
The data validation process included:
This ensured that the dataset used for modelling was clean, robust, and reliable.
The bottom-up approach involved aggregating segment-level data, such as:
This method was primarily used when detailed micro-level market data were available.
The top-down approach used macro-level indicators:
This approach was used for segments where granular data were limited or inconsistent.
To ensure accuracy, a triangulated hybrid model was used. This included:
This multi-angle validation yielded the final market size.
Market forecasts were developed using a combination of time-series modelling, adoption curve analysis, and driver-based forecasting tools.
Given inherent uncertainties, three scenarios were constructed:
Sensitivity testing was conducted on key variables, including pricing, demand elasticity, and regional adoption.